RCKT vs RNA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 12, 2026

RCKT

73.8
AI Score
VS
RCKT Wins

RNA

72.5
AI Score

Investment Advisor Scores

RCKT

Oct 12, 2026
74score
Recommendation
HOLD

RNA

Oct 12, 2026
73score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric RCKT RNA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% -21.9% RCKT
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 73.8/100 72.5/100 RCKT
Profit Margin 0.0% -184.1% RCKT
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

RCKT 1M: -26.0% · 3M: -31.9% RNA 1M: -20.8% · 3M: -32.8%

Current Technical Phase

RCKT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.7%), weak momentum, RSI 31

RSI (14): 31.0 · Price: $2.48

RNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -11.5%), weak momentum, RSI 33

RSI (14): 33.0 · Price: $8.21

Fundamentals Snapshot

Metric RCKT RNA
Market Cap — —
Forward P/E -1.9 -1.0
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% -0.2%
Gross Margin — -0.6%
Operating Margin 0.0% -7.5%
EPS -0.17 -5.44
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, RCKT is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.